Skip to main content
. 2011 Mar 28;26(4):551–560. doi: 10.3346/jkms.2011.26.4.551

Table 1.

Clinical characteristics of patients who underwent the high dose methotrexate based-combination chemotherapy for primary central nervous system lymphoma (n = 52)

graphic file with name jkms-26-551-i001.jpg